Unlisted holdings
% of total assets |
---|
N/R |
Please note that the percentage of unlisted holdings is displayed for companies that have reported this data to the AIC. “N/R” means the data has not been reported to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 30/11/2023
Investment | % of total assets |
---|---|
Option Care Health Inc | 6.9 |
Insmed Inc | 6.9 |
Axonics Inc | 6.9 |
Evolent Health Inc Class A | 6.6 |
Exact Sciences Corp | 6.4 |
Intuitive Surgical Inc | 5.2 |
Pacific Biosciences of California Inc | 5.1 |
Apellis Pharmaceuticals Inc | 4.8 |
Bio-Rad Laboratories Inc Class A | 4.8 |
Charles River Laboratories International Inc | 4.8 |
Geographic breakdown
Data as at : 31/03/2024
Country | % of total assets |
---|---|
USA | 100.0 |
Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.
Industry breakdown
Data as at : 30/11/2023
Industry | % of total assets |
---|---|
Healthcare | 100.0 |
Asset breakdown
Data as at : 30/11/2023
Asset | % of total assets |
---|---|
Stock | 100.0 |
Detailed asset breakdown
Data as at : 30/11/2023
Asset | % of total assets |
---|---|
North America - stock | 96.2 |
Asia (excl Japan) - stock | 2.7 |
Other - stock | 1.2 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.